SVSPX
Price
$306.99
Change
-$2.44 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.7B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

SVSPX vs VSTSX

SVSPX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
SVSPX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVSPX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. SVSPX (1.7B). VSTSX pays higher dividends than SVSPX: VSTSX (1.07) vs SVSPX (0.91). SVSPX was incepted earlier than VSTSX: SVSPX (34 years) vs VSTSX (10 years). SVSPX (0.17) is less costly to investors than VSTSX (0.01). VSTSX is a more actively managed with annual turnover of: 3.00 vs. SVSPX (2.00). SVSPX has a lower initial minimum investment than VSTSX: SVSPX (10000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. SVSPX (14.12). VSTSX return over 5 years is better than : 66.56 vs. SVSPX (19.64).
SVSPXVSTSXSVSPX / VSTSX
Total Expense Ratio0.160.011,570%
Annual Report Gross Expense Ratio0.170.011,720%
Fund Existence34 years10 years-
Gain YTD11.27211.205101%
Front LoadN/AN/A-
Min. Initial Investment1000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.7B2.3T0%
Annual Yield % from dividends0.911.0785%
Returns for 1 year14.1221.4866%
Returns for 3 years35.6967.0653%
Returns for 5 years19.6466.5630%
Returns for 10 years79.99239.5333%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I